Profile of Dr Petter Bjorquist
PhD in Biology/Biochemistry from Gothenburg University. 50 + publications in peer reviewed journals, several book chapters and patents. Ten years within AstraZeneca R&D in Cardiovascular Diseases, twelve years at Cellartis/Cellectis as VP Regenerative Medicine, responsible for e.g. the major collaboration with Novo Nordisk on development of a human embryonic stem cell derived beta cell transplantation for diabetes. As of February 2014, CEO of VERIGRAFT AB, a pioneering company within advanced tissue engineering, transplantation and regenerative medicine.